Ibrahim Nassour, MD, MSCS - Research

Research at a glance

Top areas of exploration

Pancreatic Neoplasms , 23 publications
Adenocarcinoma , 17 publications
Robotic Surgical Procedures , 12 publications
Pancreaticoduodenectomy , 12 publications

Research activity

92 publications

1,539 citations

Why is this important?

Active clinical trials

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy鈥�

Investigator: Ibrahim Nassour
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

92 publications

2018

Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

鈥�

2018

Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.

Gastroenterology

鈥�

2018

Minimally Invasive Versus Open Pancreaticoduodenectomy: A Propensity-matched Study From a National Cohort of Patients.

Annals of surgery

鈥�

2018

Racial and ethnic disparities in a national cohort of ampullary cancer patients

Journal of Surgical Oncology

鈥�

2018

Reply to Grant, William: Obesity and vitamin D status may help explain the racial and ethnic disparities in ampullary cancer survival rates

Journal of Surgical Oncology

网红黑料